FinTrust Capital Advisors’s Globus Medical GMED Stock Holding History

FinTrust Capital Advisors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$501	Hold	7	–	–	﹤0.01%	1314
2024 Q2	$480	Hold	7	–	–	﹤0.01%	1309
2024 Q1	$376	Hold	7	–	–	﹤0.01%	1219
2023 Q4	$374	Hold	7	–	–	﹤0.01%	1200
2023 Q3	$348	Sell	7 -423	-98%	-$23.7K	﹤0.01%	1183
2023 Q2	$31.9K	Hold	430	–	–	0.01%	534
2023 Q1	$31.9K	Hold	430	–	–	0.01%	533
2022 Q4	$31.9K	Hold	430	–	–	0.01%	532
2022 Q3	$28K	Buy	430 +20	+5%	+$1.2K	0.01%	639
2022 Q2	$23K	Buy	410 +79	+24%	+$5.19K	0.01%	701
2022 Q1	$24K	Hold	331	–	–	0.01%	716
2021 Q4	$24K	Buy	331 +30	+10%	+$2.18K	0.01%	694
2021 Q3	$23K	Hold	301	–	–	0.01%	705
2021 Q2	$23K	Hold	301	–	–	0.01%	728
2021 Q1	$19K	Sell	301 -89	-23%	-$5.64K	0.01%	730
2020 Q4	$25K	Buy	+390	New	+$22.4K	0.01%	622

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

HRCM

Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

FinTrust Capital Advisors's GMED Position: Q3 2024 in Review

FinTrust Capital Advisors held its Globus Medical (GMED) position steady in Q3 2024 at 7 shares worth $501. The position accounts for ﹤0.01% of the portfolio, ranked #1314.

FinTrust Capital Advisors first reported a position in GMED in Q4 2020 and has held it in 16 quarters since. The position peaked at $31.9K in Q2 2023. 449 funds tracked by Wall St. Rank hold GMED as of Q3 2024.

FinTrust Capital Advisors held 7 shares of Globus Medical worth $501 as of Q3 2024.
FinTrust Capital Advisors left its Globus Medical share count unchanged in Q3 2024.
Globus Medical made up ﹤0.01% of FinTrust Capital Advisors's portfolio in Q3 2024, its #1314 holding.
FinTrust Capital Advisors first reported a position in Globus Medical in Q4 2020 and has held it in 16 quarters since.
FinTrust Capital Advisors's Globus Medical position peaked at $31.9K in Q2 2023.
449 funds tracked by Wall St. Rank held Globus Medical as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.